PRIMECAP Management's position in Albemarle is currently worth $193 Million. That's 0.15% of their equity portfolio (96th largest holding). The investor owns 2.83% of the outstanding Albemarle stock. The first Albemarle trade was made in Q3 2018. Since then PRIMECAP Management bought shares eleven more times and sold shares on fifteen occasions. The investor's estimated purchase price is $339 Million, resulting in a loss of 43%.
Chris Grisanti, MAI Capital Management chief equity strategist, joins ''The Exchange'' to discuss how to trade Hersehy, Pfizer, Bristol Myers, Albemarle, and...
MetLife Investment Management LLC cut its position in shares of Albemarle Co. (NYSE:ALB – Free Report) by 8.8% during the 2nd quarter, according to its most ...
Management sees powerful growth over the next five years.
KG&L Capital Management LLC grew its position in Albemarle Co. (NYSE:ALB) by 13.9% during the third quarter, Holdings Channel.com reports. The firm owned 2,0...